Related Experiment Video
Updated: Jan 7, 2026
Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
Continuous transcutaneous CO2 monitoring in VLBW infants on high-frequency ventilation
Agustin Bernatzky1,2, Yanin Fontana Stiglich3,4, Maria Brandani3,4
1Division of Neonatology, Department of Pediatrics, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina. agustin.bernatzky@hospitalitaliano.org.ar.
Insights
Continuous transcutaneous CO₂ monitoring in preterm infants significantly reduced hypocapnia and hypercapnia episodes. This technology also decreased blood sampling needs, improving patient care and safety.
Area of Science:
- Neonatal intensive care
- Respiratory monitoring
- Pediatric ventilation
Background:
- Hypocapnia and hypercapnia pose significant risks to preterm infants.
- Continuous transcutaneous CO₂ (tCO₂) monitoring offers a potential solution to manage pCO₂ levels and reduce blood draws.
Purpose of the Study:
- To evaluate the impact of continuous transcutaneous CO₂ monitoring on blood gas stability in very low birth weight (VLBW) infants.
- To assess the association between tCO₂ monitoring and neonatal morbidities in infants on high-frequency oscillatory ventilation (HFOV).
Main Methods:
- A before-and-after study design was employed, comparing VLBW infants on HFOV before and after the implementation of tCO₂ monitoring.
- Primary outcomes included daily incidences of hypercapnia (pCO₂ > 60 mmHg) and hypocapnia (pCO₂ < 40 mmHg).
- Secondary outcomes measured blood extraction frequency and associations with neonatal morbidities.
Main Results:
- The tCO₂ monitoring group (50 infants) showed significantly reduced hypocapnia (0.15 vs. 1 episode/day) and hypercapnia (0.5 vs. 1.6 episodes/day) compared to the pre-tCO₂ group (28 infants).
- Blood sampling frequency decreased from 5 to 3 samples per day in the tCO₂ group (p < 0.01).
- A lower incidence of intraventricular hemorrhage (IVH) was observed in the tCO₂ group, with no significant differences in mortality or other morbidities.
Conclusions:
- Continuous tCO₂ monitoring is associated with improved blood gas stability, fewer hypo/hypercapnia episodes, and reduced blood sampling in VLBW infants on HFOV.
- The study suggests a potential association between tCO₂ monitoring and lower IVH rates, though causality is not established.
- Integrating tCO₂ monitoring may enhance neonatal care by minimizing complications related to CO₂ fluctuations.
Background:
Hypocapnia and hypercapnia are associated with significant morbidity in preterm infants. Continuous transcutaneous CO₂ (tCO₂) monitoring may reduce pCO₂ fluctuations and blood sampling requirements.
Methods:
A before-and-after study compared very low birth weight (VLBW) infants on high-frequency oscillatory ventilation (HFOV) before and after introducing tCO₂ monitoring. Primary outcomes were the incidences of hypercapnia (pCO₂ > 60 mmHg) and hypocapnia (pCO₂ < 40 mmHg) per day in HFOV. Secondary outcomes included the number of blood extractions per day and associations between tCO₂ monitoring and common neonatal morbidities.
Results:
The pre-tCO₂ group comprised 28 patients and the tCO₂ group 50 patients. Baseline characteristics were comparable. The tCO₂ group showed reductions in hypocapnia: 1 (IQR 0.35-2) vs. 0.15 (IQR 0-0.5), p < 0.01, and hypercapnia: 1.6 (IQR 0.87-2.6) vs. 0.5 (IQR 0.25-1), p < 0.01, as well as fewer blood samples per day: 5 (IQR 3.5-7) vs. 3 (IQR 2.5-4), p < 0.01. The tCO₂ group also showed a lower incidence of IVH, with no differences in mortality, transfusions, or other morbidities.
Conclusion:
Continuous tCO₂ monitoring in VLBW infants on HFOV was associated with fewer episodes of hypo- and hypercapnia and reduced blood sampling. An association with lower IVH rates was observed; however, causality cannot be established.
Impact:
This study evaluates the impact of transcutaneous CO₂ monitoring using a before-and-after design, analyzing its association with blood gas stability and neonatal outcomes. The use of transcutaneous CO₂ monitoring was associated with fewer episodes of hypocapnia and hypercapnia, as well as a reduced need for frequent blood sampling. A lower incidence of intraventricular hemorrhage was also observed in the group with transcutaneous CO₂ monitoring. These findings support the potential value of integrating continuous transcutaneous CO₂ monitoring into neonatal intensive care practices to enhance patient safety and reduce complications related to CO₂ fluctuations.
Related Concept Videos
01:17Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
01:20Assessment of Ventilation I: Respiratory Rate
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
01:23Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
01:23Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
01:29Assessment of Ventilation II: Respiratory Depth and Rhythm
Respiratory depth measures the volume of air inhaled or exhaled during a breath. It can vary from shallow to deep and typically remains consistent when a person is at rest or asleep. Occasionally, individuals will automatically inhale deeply, known as sighing, which inflates the lungs with more air than normal breathing.
To assess respiratory depth, observe the degree of chest excursion or movement:
01:29Mechanical Ventilation I: Indication and Settings